The utilization of paclitaxel-eluting coronary stents in small vessel diseases is effective in reducing both repeat revascularization and major adverse cardiac events within two year follow-up. To evaluate the procedural, short and long term clinical outcomes of the Taxus Liberte™ Paclitaxel-Eluting Coronary Stent in small coronary arteries of ≤ 2.5 mm in the reference vessel diameter.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
250
diameter is 2.5mm
Japanese red cross nagoya daiichi hospital
Nagoya, Aichi-ken, Japan
Target lesion revascularization rate
Time frame: within 9months
Technical success
Time frame: initial
Target lesion revascularization rate
Time frame: 12 months
Target lesion revascularization rate
Time frame: 24 months
Target vessel revascularization rate
Time frame: 12 months
Target vessel revascularization rate
Time frame: 24 months
The rate of MACE including MI due to stent thrombosis
Time frame: 12 months
The rate of MACE including MI due to stent thrombosis
Time frame: 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Higashi Cardiovascular clinic
Toyohashi, Aichi-ken, Japan
Toyohashi Heart Center
Toyohashi, Aichi-ken, Japan
Kokura memorial hospital
Kitakyushu, Fukuoka, Japan
Hoshi general hospital
Kōriyama, Fukushima, Japan
Southen tohoku research institute for neuroscience
Kōriyama, Fukushima, Japan
Gunma prefectural cardiovascular center
Maebashi, Gunma, Japan
Asahikawa medical college hospital
Asahikawa, Hokkaido, Japan
Hakodate central general hospital
Hakodate, Hokkaido, Japan
Shinko kakogawa hospital
Kakogawa, Hyōgo, Japan
...and 13 more locations